Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,168.00
Bid: 12,166.00
Ask: 12,170.00
Change: -2.00 (-0.02%)
Spread: 4.00 (0.033%)
Open: 12,114.00
High: 12,258.00
Low: 12,114.00
Prev. Close: 12,170.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON MARKET OPEN: Promising Start Amid Blue-Chip Exec Changes

Fri, 22nd Nov 2019 08:52

(Alliance News) - Stocks in London were broadly higher early Friday, after China said it wants a trade deal with US, though it did not shy away from fighting talk, and Land Securities and Rightmove both announced key executive changes.

The FTSE 100 index of London large-cap stocks was 59.31 points higher, or 0.8%, at 7,297.86 on Friday morning. The mid-cap FTSE 250 was 15.20 points up, or 0.1%, at 20,385.06, but the AIM All-Share was 0.2% higher at 904.07.

The Cboe UK 100 index was 1.0% higher at 12,383.68. The Cboe UK 250 was 0.5% up early on Friday at 18,354.37, but the Cboe UK Small Companies was marginally lower at 11,272.21.

Property developer Land Securities was 0.6% higher after it said Mark Allan will join as chief executive after leaving his role as CEO of St Modwen Properties in May next year. Allan was formerly was the CEO of student accommodation provider Unite Group between 2006 and 2016, Landsec noted.

He is to join the FTSE 100 firm "no later than June 1, 2020", Landsec added.

St Modwen, down 1.5%, making it one of the worst FTSE 250 performers, said it was "disappointed" to lose Allan but has begun the process to replace him.

Also making a key executive change was real estate firm Rightmove, up 1.0% in early dealings, naming Andrew Fisher as non-executive chair with effect on January 1. He is currently a non-executive director at retailer Marks & Spencer and insurance comparison site Moneysupermarket.com, and was formerly executive chair at music recognition mobile app Shazam.

FTSE 250 gambling software firm Playtech was down 1.8% early on Friday after it warned adjusted earnings before interest, tax, depreciation and amortisation will be "a little below consensus" in 2019.

The company, which provides betting terminals for the likes of Labrokes and Paddy Power, said: "Following a positive start to the second half, trading conditions in TradeTech have been highly challenging during September and October."

However, Playtech said trading in its Core B2B Gambling and Snaitech arms "continues to exceed management expectations, while trading in Asia has remained stable". Revenue in Regulated B2B Gambling was up 12% on a year before in the four months from July to October.

Also issuing a full-year earnings warning was Coats Group, down 11% and languishing at the foot of the FTSE 250 index.

On the back of a "slower sales performance", the industrial threads maker is now guiding for adjusted operating profit between USD196 million and USD201 million.

Adjusted operating profit in 2018 came in at USD195 million.

Elsewhere on the London Main Market, investment manager Brooks Macdonald said it will part with up to GBP39 million in cash to acquire Edinburgh-based Cornelian Asset Managers.

Brooks said: "The total net consideration is expected to be up to GBP39 million, with initial consideration being GBP31 million, of which GBP22 million will be paid in cash and GBP9m in Brooks Macdonald shares."

Brooks will launch a share placing to raise GBP30 million. The firm will price its shares at 1,775 pence apiece. The stock was down 1.9% at 1,790.0 pence each.

Pharma giant AstraZeneca edged 1.0% higher following Thursday's late news that its drug Calquence had been approved in the US for adults patients with chronic lymphocytic leukaemia or small lymphocytic lymphoma.

The approval by the US Food & Drug Administration results from positive analyses from two phase 3 clinical trials, Elevate-TN in patients with previously untreated CLL and Ascend in patients with relapsed or refractory CLL.

In European equities, the CAC 40 index in Paris was up 0.6% and the DAX 30 in Frankfurt also 0.6% higher.

Stocks in the US ended in the red on Thursday. The S&P 500, the Dow Jones Industrial Average and Nasdaq Composite all closed 0.2% lower.

Stocks in Asia were mixed on Friday, the Nikkei 225 closed 0.3% higher in Tokyo, with Hong Kong's Hang Seng 0.5% higher in late trade. The Shanghai Composite closed 0.6% lower in China.

"Global markets remained focused on US-China trade negotiations, taking a modicum of comfort on reports that Chinese VP Liu has invited US Trade Rep Lighthizer to Beijing for further talks," Lloyds bank research said.

On Friday, President Xi Jinping said China wanted to hammer out a deal but was "not afraid" to fight back when necessary. He told former US officials and other foreign dignitaries at a meeting in Beijing that he wanted to "work for a phase-one agreement on the basis of mutual respect and equality".

The remarks came two days after Donald Trump complained Beijing had not made sufficient concessions so far, making him reluctant to conclude a bargain.

Mining stocks in London received a slight uptick following the latest trade war developments.

Antofagasta topped the blue-chip index, rising 2.5% early on Friday. Glencore was just behind, 2.4% higher, with BHP and Rio Tinto both up 1.7%.

A slew of flash PMI readings will provide some distraction from the trade tit-for-tat, with manufacturing and services numbers from Japan, Germany, the eurozone, the UK and the US.

In Japan, the Jibun Bank flash composite PMI registered a slight rise in November but pointed to a "strongly possibility" the country's economy will contract in the fourth quarter.

The flash composite purchasing manager's index read 49.9 in November, up from October's actual figure of 49.1. The flash manufacturing PMI showed a slight rise to 48.6 in November from 48.4 the previous month, while the flash services PMI indicated a rise into expansionary territory, increasing to 50.4 from 49.7.

In Germany, the flash composite PMI was 49.2 in November, up from 48.9 in October. The manufacturing PMI improved, but services slipped a bit.

The eurozone reading is due at 0900 GMT, before the UK reading at 0930 GMT.

"We look for a small decline in the November manufacturing PMI to 49.0, but a rise in the services PMI to 50.5. These numbers remain consistent with flat or slightly negative quarterly growth," Lloyds said, ahead of the UK print.

By Eric Cunha; ericcunha@alliancenews.com

Copyright 2019 Alliance News Limited. All Rights Reserved.

More News
8 Feb 2024 07:50

LONDON BRIEFING: Unilever sets new buyback; Astra profit surges

(Alliance News) - Stocks in London are called to open slightly higher on Thursday, as investors eye a busy day of earnings.

Read more
2 Feb 2024 08:38

AstraZeneca celebrates latest successful trial of acoramidis in Japan

(Alliance News) - AstraZeneca PLC on Friday said positive results from a Phase 3 trial of acoramidis are consistent with global findings, bring the drug closer to regulatory submission in Japan.

Read more
2 Feb 2024 06:22

TOP NEWS: US sends drugmakers initial offers in Medicare price talks

(Alliance News) - The US government said it was making initial offers to drugmakers Thursday as part of Medicare negotiations meant to lower the prices many older Americans would pay for 10 medicines.

Read more
1 Feb 2024 15:52

UK earnings, trading statements calendar - next 7 days

Friday 2 February 
YouGov PLCTrading Statement
Monday 5 February 
Home REIT PLCTrading Statement
Porvair PLCFull Year Results
Trident Royalties PLCTrading Statement
Vodafone Group PLCTrading Statement
Tuesday 6 February 
Alumasc Group PLCHalf Year Results
BP PLCFull Year Results
Filtronic PLCHalf Year Results
Mattioli Woods PLCHalf Year Results
Renishaw PLCHalf Year Results
Virgin Money UK PLCTrading Statement
Wednesday 7 February 
Ashmore Group PLCHalf Year Results
Barratt Developments PLCHalf Year Results
HydrogenOne Capital Growth PLCTrading Statement
Phoenix Spree Deutschland LtdTrading Statement
PZ Cussons PLCHalf Year Results
Smurfit Kappa Group PLCFull Year Results
UK Commercial Property REIT LtdTrading Statement
Thursday 8 February 
Anglo American PLCTrading Statement
AstraZeneca PLCFull Year Results
British American Tobacco PLCFull Year Results
Compass Group PLCTrading Statement
Redrow PLCHalf Year Results
SSE PLCTrading Statement
Unilever PLCFull Year Results
  
Comments and questions to newsroom@alliancenews.com
  
A full 21-day events calendar is provided each day with a subscription to Alliance News UK Professional.
  
Copyright 2024 Alliance News Ltd. All Rights Reserved.

Read more
29 Jan 2024 08:19

TOP NEWS: AstraZeneca, Daiichi's Enhertu granted priority review in US

(Alliance News) - AstraZeneca PLC on Monday said its cancer drug conjugate received priority review by the Food & Drug Administration in the US for patients with metastatic HER2-positive solid tumours.

Read more
22 Jan 2024 11:45

BioNTech challenges AstraZeneca with breast cancer precision drug trial

FRANKFURT, Jan 22 (Reuters) - BioNTech and its partner Duality Biologics said on Monday they initiated a late-stage trial testing their precision drug against a certain type of breast cancer, taking on a rival partnership between AstraZeneca and Daiichi Sankyo.

Read more
19 Jan 2024 09:28

TOP NEWS: AstraZeneca's Voydeya receives approval in Japan for PNH

(Alliance News) - AstraZeneca PLC on Friday said its inhibitor Voydeya, also known as danicopan, received approval in Japan for adults with paroxysmal nocturnal haemoglobinuria, or PNH.

Read more
16 Jan 2024 17:17

FTSE 100 hits one-month low, precious miners biggest drag

FTSE 100 down 0.5%, FTSE 250 flat

*

Read more
16 Jan 2024 16:17

London close: Stocks finish lower as wage growth eases

(Sharecast News) - London's stock markets finished in the red on Tuesday, as investors assessed the latest UK jobs data.

Read more
16 Jan 2024 11:58

LONDON MARKET MIDDAY: FTSE 100 falls despite cooler UK wage growth

(Alliance News) - The FTSE 100 in London was down at midday Tuesday, as investors nervously eye Wednesday's UK inflation data and what it will mean for interest rates.

Read more
16 Jan 2024 09:14

LONDON BROKER RATINGS: UBS raises GSK and cuts AstraZeneca

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning:

Read more
16 Jan 2024 08:15

UBS downgrades AstraZeneca to 'sell'

(Sharecast News) - UBS has downgraded AstraZeneca and upgraded rival GSK as part of its latest review of the European pharmaceutical sector.

Read more
9 Jan 2024 10:50

Novartis in advanced talks to buy Cytokinetics- source

Jan 9 (Reuters) - Swiss drugmaker Novartis is in the lead to acquire Cytokinetics in a deal that could value the drug developer at well over $10 billion, a source familiar with the matter said on Monday.

Read more
8 Jan 2024 14:08

Late M&A bonanza stokes healthcare dealmakers ahead of JPMorgan conference

NEW YORK, Jan 5 (Reuters) - Healthcare dealmakers are making their way to San Francisco for a major industry conference, optimistic that more deals are in the offing after a wave of biotech company takeovers at the end of last year.

Read more
6 Jan 2024 17:44

Late M&A bonanza stokes healthcare dealmakers ahead of JPMorgan conference

NEW YORK, Jan 5 (Reuters) - Healthcare dealmakers are making their way to San Francisco for a major industry conference, optimistic that more deals are in the offing after a wave of biotech company takeovers at the end of last year.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.